What Happened?
New York, NY-based Axsome-Therapeutics Appointed Herriot Tabuteau as Chief Executive Officer
About the Company
Axsome Therapeutics is a biopharmaceutical company developing novel therapies for the treatment of CNS disorders. Axsome has a balanced portfolio of clinical development stage as well as research stage product candidates. The company is based in New York City.
About the Person
Herriot Tabuteau is Chief Executive Officer at Axsome Therapeutics. Previously, Herriot held various senior HR leadership roles in the industry.
Info Source
News
Short Profile